World Meningitis Day
Meningitis affects 1 million people globally each year. The disease, which can kill a person in 24 hours, is caused by inflammation of the brain and spinal cord. Many types of bacteria, and some viruses and fungi, cause meningitis. Some types can be prevented with safe and effective vaccines; others cannot. The organizers of World Meningitis Day (April 24) plan to highlight the many causes of meningitis. The ASBMB is observing the day by sharing articles on various meningitis-causing pathogens.
Fungal meningitis
Cryptococcal meningitis is responsible for an estimated 15 percent of all AIDS-related deaths. Antifungals, which some immunocompromised patients must take for life to prevent meningitis, often target biosynthetic pathways including lipid biogenesis. A recent study in the Journal of Lipid Research undertook a comprehensive catalogue of lipids in various strains of Cryptococcus and described a number of possible future antifungal targets. .
A paper in the Journal of Biological Chemistry described the structure of an enzyme called ADS lyase from Cryptococcus neoformans, which may be another antifungal drug target.
Viral Meningitis
Herpes viruses can induce meningitis. An article in ͵͵ & Cellular Proteomics introduced a database of protein-protein interactions within herpesvirus-1. The database predicted some hitherto unknown interactions within the virus, and may in the future be used to organize proteomics findings and identify new drug targets. Access the open-access or the
Viral meningitis sometimes arises as a fatal complication of hand, foot and mouth disease caused by enterovirus 71. A paper in the Journal of Biological Chemistry described an unexpected mechanism by which the virus blocks cell signaling to circumvent the immune system’s antiviral response. .
Bacterial meningitis
Vaccination against Neisseria meningitidis, a leading cause of bacterial meningitis, can be costly because researchers must grow the bacterium in culture to isolate oligosaccharide antigens. An article in the Journal of Biological Chemistry reports the development of enzyme-based tools to make oligosaccharides in vitro, which could someday lower the .
Trafficking of N. meningitidis lipoproteins to the outer bacterial membrane determines which antigens are available for immune recognition. A paper in ͵͵ & Cellular Proteomics investigated how N. meningitidis and other Gram-negative bacteria transport these proteins.
Enterococcus faecalis is a commensal organism in the gastrointestinal tract, but can form dangerous biofilms on implanted medical devices that can lead to complications like bacterial meningitis. in ͵͵ & Cellular Proteomics identified markers of biofilm formation ability that might help develop drugs to target biofilm formation and prevent infection.
Bacteria from the birth canal can be associated with life-threatening meningitis in newborns. Fortunately for infants, oligosaccharides from human milk can protect them from the same neonatal pathogens. A paper in the Journal of Biological Chemistry, , isolated the human milk oligosaccharide responsible for the protective effect.
Microglia are immune cells in the brain that respond to bacterial meningitis by launching an inflammatory response. A paper in the Journal of Biological Chemistry reported changes in microglial iron transport in response to activation.
The cause of meningitis is sometimes diagnosed by measuring the amount of protein in a spinal tap to find out whether the blood-brain barrier is intact. An article in the Journal of Lipid Research showed that disruption of the barrier raises the level of oxysterol 7-HOCA, along with protein, in the cerebrospinal fluid. Therefore, 7-HOCA could serve as a secondary diagnostic marker for bacterial meningitis and related conditions.
Enjoy reading ASBMB Today?
Become a member to receive the print edition four times a year and the digital edition weekly.
Learn moreGet the latest from ASBMB Today
Enter your email address, and we’ll send you a weekly email with recent articles, interviews and more.
Latest in Science
Science highlights or most popular articles
Guiding grocery carts to shape healthy habits
Robert “Nate” Helsley will receive the Walter A. Shaw Young Investigator in Lipid Research Award at the 2025 ASBMB Annual Meeting, April 12–15 in Chicago.
Quantifying how proteins in microbe and host interact
“To develop better vaccines, we need new methods and a better understanding of the antibody responses that develop in immune individuals,” author Johan Malmström said.
Leading the charge for gender equity
Nicole Woitowich will receive the ASBMB Emerging Leadership Award at the 2025 ASBMB Annual meeting, April 12–15 in Chicago.
CRISPR gene editing: Moving closer to home
With the first medical therapy approved, there’s a lot going on in the genome editing field, including the discovery of CRISPR-like DNA-snippers called Fanzors in an odd menagerie of eukaryotic critters.
Finding a missing piece for neurodegenerative disease research
Ursula Jakob and a team at the University of Michigan have found that the molecule polyphosphate could be what scientists call the “mystery density” inside fibrils associated with Alzheimer’s, Parkinson’s and related conditions.
From the journals: JLR
Enzymes as a therapeutic target for liver disease. Role of AMPK in chronic liver disease Zebrafish as a model for retinal dysfunction. Read about the recent JLR papers on these topics.